Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin

Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin

US Patent 10092571 · Granted Oct 9, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition, methods for treating and uses thereof2025
Pharmaceutical composition, methods for treating and uses thereof2025
Use of a DPP-4 inhibitor in SIRS and/or sepsis2025
Use of a DPP-4 inhibitor in SIRS and/or sepsis2025
Pharmaceutical composition, methods for treating and uses thereof2025
Uses of DPP IV inhibitors2024
Uses of DPP IV inhibitors2024
Pharmaceutical composition, methods for treating and uses thereof2024
Pharmaceutical composition, methods for treating and uses thereof2024
Vasoprotective and cardioprotective antidiabetic therapy2024
Vasoprotective and cardioprotective antidiabetic therapy2024
Treatment for diabetes in patients with insufficient glycemic control despite th2024